ID
13254
Description
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01242774
Link
https://clinicaltrials.gov/show/NCT01242774
Keywords
Versions (1)
- 1/26/16 1/26/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
January 26, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myeloid Leukemia (AML) NCT01242774
Eligibility Acute Myeloid Leukemia (AML) NCT01242774
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
cytogenetic profile
Data type
boolean
Alias
- UMLS CUI [1]
- C0010802
Description
cns leukemia
Data type
boolean
Alias
- UMLS CUI [1]
- C1332884
Description
deacetylase inhibitors
Data type
boolean
Alias
- UMLS CUI [1]
- C1333261
Description
cardiac function
Data type
boolean
Alias
- UMLS CUI [1]
- C0232164
Description
pregnancy or lactation
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
contraception
Data type
boolean
Alias
- UMLS CUI [1]
- C0700589
Similar models
Eligibility Acute Myeloid Leukemia (AML) NCT01242774
- StudyEvent: Eligibility
C0232741 (UMLS CUI [2])
C0006147 (UMLS CUI [2])